Why is Trident Texofab falling/rising?

As of 22-Aug, Trident Texofab Ltd's stock price is rising, currently at Rs. 230.75, reflecting an increase of Rs. 3.75 or 1.65%. The stock has recently hit a new 52-week high of Rs. 235 and has been on a consecutive gain streak for the last seven days, accumulating a total return of 7.65% during this period. Over the past week, the stock has outperformed the sector by 2.04%. Additionally, Trident Texofab has shown impressive long-term performance, with a remarkable 426.35% return over the past year and a 507.24% increase over the last five years. The company has also reported positive financial results for the last three consecutive quarters, including a 24.20% growth in net sales and the highest operating profit margin at 7.37%.
In the broader market context, Trident Texofab's recent performance stands out as it has significantly outperformed the Sensex, which has only gained 0.88% over the past week and is down 1.07% over the past month. This strong relative performance indicates that investor sentiment towards Trident Texofab remains positive, despite a noted decline in delivery volume by 32.3% against the five-day average, suggesting a potential decrease in investor participation. Overall, the stock's upward trajectory is supported by its strong financial results and consistent market-beating performance, positioning it favorably compared to broader market trends.